 |
Textbook and Publication Errata
Handbook on Injectable Drugs, 13th
Edition
On page 194, in the Y-Site Injection Compatibility Table
for bivalirudin, the entry in the rightmost column for prochlorperazine
edisylate should be "I," not "C." The
information in the "Remarks" column for this drug
combination correctly describes the incompatibility, i.e.,
a gross white precipitate forms immediately if the two drugs
are administered simultaneously through the same Y site.
This correction also applies to the current Handbook on Injectable
Drugs Interactive CD. When bivalirudin is the first drug and
prochlorperazine edisylate is the second, third, fourth, or
fifth drug to be mixed, a red X should appear on the screen,
indicating that the two drugs are incompatible. A green check
mark is incorrect (see screen shot below).
|
200 Lakeside Drive, Suite 200, Horsham, PA 19044,
Phone: (215) 947-7797, Fax: (215) 914-1492
© 2012 Institute for Safe Medication Practices. All rights reserved
|
|
|
 |
